drugset / Trial / NCT01845441

Use of Dexmedetomidine in Acute Stroke and Cerebral Vasospasm Interventions

NCT01845441

RandomizedParallel-groupDouble-blindSupportive care

Summary

Dexmedetomidine is a unique sedative medication able to provide sedation without causing respiratory depression and maintaining neurological functions. Patients having an acute ischemic stroke and need to undergo endovascular therapy require constant assessment of their neurological status prior, during and after the interventional procedure. In this study the investigators will compare the efficacy of Dexmedetomidine to other standard sedative medications in providing optimal sedative effect while maintaining neurological function.

Timeline

Start
2012-04
Primary completion
2021-12
Completion
2021-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.3 ug/kg Intravenous
Comparator Fentanyl Other / unclassified 50 ug Intravenous
Comparator Midazolam Small molecule 0.5 mg Intravenous